CA1052245A - Detection of breast cancer - Google Patents

Detection of breast cancer

Info

Publication number
CA1052245A
CA1052245A CA245,266A CA245266A CA1052245A CA 1052245 A CA1052245 A CA 1052245A CA 245266 A CA245266 A CA 245266A CA 1052245 A CA1052245 A CA 1052245A
Authority
CA
Canada
Prior art keywords
breast cancer
breast
leukocytes
antigen
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA245,266A
Other languages
English (en)
French (fr)
Other versions
CA245266S (en
Inventor
Norman Grosser
David M.P. Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1052245A publication Critical patent/CA1052245A/en
Expired legal-status Critical Current

Links

Classifications

    • G01N33/57515—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA245,266A 1975-02-28 1976-02-09 Detection of breast cancer Expired CA1052245A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/554,039 US3999944A (en) 1975-02-28 1975-02-28 Detection of breast cancer

Publications (1)

Publication Number Publication Date
CA1052245A true CA1052245A (en) 1979-04-10

Family

ID=24211805

Family Applications (1)

Application Number Title Priority Date Filing Date
CA245,266A Expired CA1052245A (en) 1975-02-28 1976-02-09 Detection of breast cancer

Country Status (2)

Country Link
US (1) US3999944A (Sortimente)
CA (1) CA1052245A (Sortimente)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055851B (it) * 1974-08-30 1982-01-11 Behringwerke Ag Particelle indicatirci per diagnosi in vitro
SE7604807L (sv) * 1975-05-05 1976-11-06 N Proisvodstveno Ob Veterinarn Sett och medel for diagnostisering av cancer
US4043757A (en) * 1975-05-20 1977-08-23 Ortho Pharmaceutical Corporation Method for detection of human mammary carcinoma
AU506539B2 (en) * 1976-05-27 1980-01-10 F. Hoffmann-Laroche & Co. Aktiengesellschaft Tumour detection
DE2729893A1 (de) * 1977-05-23 1978-11-30 Sol Prof Spiegelman Verfahren zum nachweis von krebs und mittel zur durchfuehrung des verfahrens
US4379839A (en) * 1977-05-23 1983-04-12 The Trustees Of Columbia University In The City Of New York Method for detecting cancer
US4115062A (en) 1977-06-13 1978-09-19 Purdue Research Foundation Cancer detection by serum analysis of glycolipids
CS202434B1 (en) * 1979-01-09 1981-01-30 Ivan Dolejsi Method of detec ing the malign ulcers from the the urine samples
US4246344A (en) * 1979-04-09 1981-01-20 Minnesota Mining And Manufacturing Company Method of detecting adherent cells
US4229414A (en) * 1979-04-27 1980-10-21 Ciba-Geigy Corporation Adherence column
US4298334A (en) * 1979-11-26 1981-11-03 Honeywell Inc. Dynamically checked safety load switching circuit
US4343895A (en) * 1980-05-23 1982-08-10 Stephen Sugaar Encapsulated antigenic tumor specific substances and methods for detecting cancer using said substances
US4368423A (en) * 1981-01-13 1983-01-11 Liburdy Robert P Apparatus for determining cell membrane dielectric breakdown
US4472506A (en) * 1981-01-13 1984-09-18 Liburdy Robert P Method for determining cell membrane dielectric breakdown
US4426446A (en) 1981-02-03 1984-01-17 Hoffmann-La Roche Inc. Leucocyte adherence inhibition assay for detection of cancer
US4455379A (en) * 1981-07-21 1984-06-19 Mount Sinai School Of Medicine Of The City University Of New York Leukocyte adherence inhibition assay
US4666834A (en) * 1981-07-21 1987-05-19 Mount Sinai School Of Medicine Of The City University Of New York Leukocyte adherence inhibition assay
EP0160640A1 (en) * 1982-12-22 1985-11-13 University Of Queensland Microassay of cell adherence
DE3483252D1 (de) * 1983-12-05 1990-10-25 Asahi Chemical Ind Verfahren zur induktion von antitumorimmunozyten, verfahren zur herstellung von antitumorimmunozyten und durch das verfahren hergestellte antitumorimmunozyten.
US4716107A (en) * 1984-02-29 1987-12-29 Gross Robert L Method for diagnosis of A.I.D.S.
DE3572033D1 (en) * 1984-02-29 1989-09-07 Gross Albert A And Dittmer Tho Method for diagnosis of a.i.d.s.
US4851510A (en) * 1984-11-30 1989-07-25 Wadley Technologies, Inc. Monoclonal antibodies to novel melanoma-associated antigens
WO1988000344A1 (en) * 1986-07-03 1988-01-14 Bio-Rad Laboratories, Inc. Peptide fragments of organ-specific neoantigens

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1484727A (fr) * 1966-04-19 1967-06-16 Réactif immunologique et son procédé d'obtention
CA941739A (en) * 1968-04-30 1974-02-12 Ortho Pharmaceutical Corporation Diagnostic reagent for infectious mononucleosis and process for making and method of using the same
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine
US3867363A (en) * 1970-06-01 1975-02-18 Hans John Hansen Carcinoembryonic antigens
ZA723264B (en) * 1972-10-13 1974-08-28 H Van Til Improvements in toys

Also Published As

Publication number Publication date
USB554039I5 (Sortimente) 1976-02-24
US3999944A (en) 1976-12-28

Similar Documents

Publication Publication Date Title
CA1052245A (en) Detection of breast cancer
Code Histamine in blood
CA2185535C (en) A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
CA1094476A (en) Application of protein - protein interaction as an assay for the detection of cancer
US20030119077A1 (en) Method of enriching rare cells
WO2013063981A1 (zh) 鉴别从人或动物生物体液中富集的非血源性有核细胞的方法
Maderazo et al. Serum-associated inhibition of leukotaxis in humans with cancer
Sandler et al. The effect of serotonin (5-hydroxytryptamine) and derivatives on guanosine 3', 5'-monophosphate in human monocytes.
JPH08506421A (ja) 細胞関連分子を検出し、その量を測定するための方法および器具
Caraux et al. Human autologous rosettes: I. Mechanism of binding of autologous erythrocytes by T cells
PT603107E (pt) Processo para a quantificacao simultanea numa unica medicao dos principais tipos de linfocitos humanos e dos seus subconjuntos
Hakala et al. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract
Pauly et al. Elevated thymidine phosphorylase activity in the plasma and ascitic fluids of tumor-bearing animals
Arakelyan et al. Flow virometry to analyze antigenic spectra of virions and extracellular vesicles
Russo et al. Studies with biotinylated RBC:(1) use of flow cytometry to determine posttransfusion survival and (2) isolation using streptavidin conjugated magnetic beads
US5260186A (en) Provision of density specific blood cells for the structuredness of the cytoplasmic matrix (SCM) test
Inglis et al. Effect of Bacteroides fragilis on the human erythrocyte membrane: pathogenesis of Tk polyagglutination.
Bukowski et al. Lymphocyte Subpopulations in Hoclgkin’s Disease
Bradstock et al. Expression of terminal deoxynucleotidyl transferase in malignant myeloblasts
US4081241A (en) Diagnostic process
Maurer et al. Influence of bilirubin on human platelets
JP2553606B2 (ja) 密度特異血球の分離及び使用方法
Okazaki et al. Prostaglandins and asthma: The use of blood components for metabolic studies
Hill et al. The uptake and utilization of chlorambucil by lymphocytes from patients with chronic lymphocytic leukaemia
Inami et al. Micro-hemagglutination tests for detection of native and single-strand DNA antibodies and circulating DNA antigen